Travel Vaccines Market Size, Share, Growth, Analysis, Report, 2034

Download Free Sample

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Travel Vaccines Market Size Analysis

Global Travel Vaccines Market Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value

North America Market Analysis

Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value
U.S.
1. By Composition
  1. Introduction
    1. Composition By Value
  2. Mono Vaccines
    1. By Value
  3. Combination Vaccines
    1. By Value
2. By Disease
  1. Introduction
    1. Disease By Value
  2. Hepatitis A
    1. By Value
  3. DPT
    1. By Value
  4. Yellow Fever
    1. By Value
  5. Typhoid
    1. By Value
  6. Hepatitis B
    1. By Value
  7. Measles and Mumps
    1. By Value
  8. Rabies
    1. By Value
  9. Meningococcal
    1. By Value
  10. Varicella
    1. By Value
  11. Japanese Encephalitis
    1. By Value
  12. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Domestic Travel
    1. By Value
  3. Outbound Travel
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Adult Vaccines
    1. By Value
  3. Pediatric Vaccines
    1. By Value
Canada

Europe Market Analysis

Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value
U.K.
1. By Composition
  1. Introduction
    1. Composition By Value
  2. Mono Vaccines
    1. By Value
  3. Combination Vaccines
    1. By Value
2. By Disease
  1. Introduction
    1. Disease By Value
  2. Hepatitis A
    1. By Value
  3. DPT
    1. By Value
  4. Yellow Fever
    1. By Value
  5. Typhoid
    1. By Value
  6. Hepatitis B
    1. By Value
  7. Measles and Mumps
    1. By Value
  8. Rabies
    1. By Value
  9. Meningococcal
    1. By Value
  10. Varicella
    1. By Value
  11. Japanese Encephalitis
    1. By Value
  12. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Domestic Travel
    1. By Value
  3. Outbound Travel
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Adult Vaccines
    1. By Value
  3. Pediatric Vaccines
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value
China
1. By Composition
  1. Introduction
    1. Composition By Value
  2. Mono Vaccines
    1. By Value
  3. Combination Vaccines
    1. By Value
2. By Disease
  1. Introduction
    1. Disease By Value
  2. Hepatitis A
    1. By Value
  3. DPT
    1. By Value
  4. Yellow Fever
    1. By Value
  5. Typhoid
    1. By Value
  6. Hepatitis B
    1. By Value
  7. Measles and Mumps
    1. By Value
  8. Rabies
    1. By Value
  9. Meningococcal
    1. By Value
  10. Varicella
    1. By Value
  11. Japanese Encephalitis
    1. By Value
  12. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Domestic Travel
    1. By Value
  3. Outbound Travel
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Adult Vaccines
    1. By Value
  3. Pediatric Vaccines
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value
UAE
1. By Composition
  1. Introduction
    1. Composition By Value
  2. Mono Vaccines
    1. By Value
  3. Combination Vaccines
    1. By Value
2. By Disease
  1. Introduction
    1. Disease By Value
  2. Hepatitis A
    1. By Value
  3. DPT
    1. By Value
  4. Yellow Fever
    1. By Value
  5. Typhoid
    1. By Value
  6. Hepatitis B
    1. By Value
  7. Measles and Mumps
    1. By Value
  8. Rabies
    1. By Value
  9. Meningococcal
    1. By Value
  10. Varicella
    1. By Value
  11. Japanese Encephalitis
    1. By Value
  12. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Domestic Travel
    1. By Value
  3. Outbound Travel
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Adult Vaccines
    1. By Value
  3. Pediatric Vaccines
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Composition
1. Introduction
  1. Composition By Value
2. Mono Vaccines
  1. By Value
3. Combination Vaccines
  1. By Value
By Disease
1. Introduction
  1. Disease By Value
2. Hepatitis A
  1. By Value
3. DPT
  1. By Value
4. Yellow Fever
  1. By Value
5. Typhoid
  1. By Value
6. Hepatitis B
  1. By Value
7. Measles and Mumps
  1. By Value
8. Rabies
  1. By Value
9. Meningococcal
  1. By Value
10. Varicella
  1. By Value
11. Japanese Encephalitis
  1. By Value
12. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Domestic Travel
  1. By Value
3. Outbound Travel
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Adult Vaccines
  1. By Value
3. Pediatric Vaccines
  1. By Value
Brazil
1. By Composition
  1. Introduction
    1. Composition By Value
  2. Mono Vaccines
    1. By Value
  3. Combination Vaccines
    1. By Value
2. By Disease
  1. Introduction
    1. Disease By Value
  2. Hepatitis A
    1. By Value
  3. DPT
    1. By Value
  4. Yellow Fever
    1. By Value
  5. Typhoid
    1. By Value
  6. Hepatitis B
    1. By Value
  7. Measles and Mumps
    1. By Value
  8. Rabies
    1. By Value
  9. Meningococcal
    1. By Value
  10. Varicella
    1. By Value
  11. Japanese Encephalitis
    1. By Value
  12. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Domestic Travel
    1. By Value
  3. Outbound Travel
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Adult Vaccines
    1. By Value
  3. Pediatric Vaccines
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Travel Vaccines Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

GlaxoSmithKline Pharmaceuticals Limited
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Sanofi Pasteur
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
ALK-Abelló A/S
Bavarian Nordic A/S
Crucell (Subsidiary of Johnson & Johnson)
CSL Limited
AstraZeneca PLC
Altimmune, Inc.
Abbott Laboratories
Hoffmann-La Roche, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Tejas Zamde

Research Associate